Literature DB >> 12709877

Association of human polyomavirus JC with peripheral blood of immunoimpaired and healthy individuals.

Kristina Dörries1, Silviu Sbiera, Klaus Drews, Gabriele Arendt, Christian Eggers, Rüdiger Dörries.   

Abstract

JC virus (JCV) infection is regularly asymptomatic in healthy individuals. In contrast, in immunocompromised individuals, highly activated virus replication may lead to PML. Peripheral blood cells (PBCs) are found to harbor JCV DNA in healthy and diseased individuals and it is discussed that they might be responsible for dissemination of the virus to the central nervous system (CNS) during persistence. To better understand the role of JCV DNA in PBCs for persistent infection and pathogenesis, the authors characterized the extent of JCV infection in Ficoll-gradient purified blood cells (peripheral blood mononuclear cells [PBMCs]) of healthy and human immunodeficiency virus type 1 (HIV-1)-infected individuals. Virus activation in PBMCs from healthy JCV-infected individuals was found at a rate of 0% to 38% at low polymerase chain reaction (PCR) sensitivity. In progressive multifocal leukoencephalopathy (PML) patients, a stronger signal was found, indicating increased virus activation. JCV DNA was regularly detected in T and B lymphocytes and in monocytes at low levels. However, granulocytes were shown to be the predominant reservoir of JCV DNA harboring high copy numbers. Although the overall distribution of viral genomes holds true for the population studied, in the individual, a markedly changed pattern of distribution can be found.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709877     DOI: 10.1080/13550280390195379

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  9 in total

1.  JC virus binds to primary human glial cells, tonsillar stromal cells, and B-lymphocytes, but not to T lymphocytes.

Authors:  G Wei; C K Liu; W J Atwood
Journal:  J Neurovirol       Date:  2000-04       Impact factor: 2.643

2.  JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy.

Authors:  I J Koralnik; D Boden; V X Mai; C I Lord; N L Letvin
Journal:  Neurology       Date:  1999-01-15       Impact factor: 9.910

3.  Quantification of human polyomavirus JC in brain tissue and cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy by competitive PCR.

Authors:  K Drews; T Bashir; K Dörries
Journal:  J Virol Methods       Date:  2000-01       Impact factor: 2.014

4.  Polyomavirus persistence in lymphocytes: prevalence in lymphocytes from blood donors and healthy personnel of a blood transfusion centre.

Authors:  Antonina Dolei; Valeria Pietropaolo; Eduarda Gomes; Cristiana Di Taranto; Maria Ziccheddu; Maria A Spanu; Claudio Lavorino; Mario Manca; Anna Marta Degener
Journal:  J Gen Virol       Date:  2000-08       Impact factor: 3.891

Review 5.  Viral variant nucleotide sequences help expose leukocytic positioning in the JC virus pathway to the CNS.

Authors:  P N Jensen; E O Major
Journal:  J Leukoc Biol       Date:  1999-04       Impact factor: 4.962

6.  Human polyomavirus JC latency and reactivation status in blood of HIV-1-positive immunocompromised patients with and without progressive multifocal leukoencephalopathy.

Authors:  L Andréoletti; V Dubois; A Lescieux; A Dewilde; L Bocket; H J Fleury; P Wattré
Journal:  AIDS       Date:  1999-08-20       Impact factor: 4.177

7.  Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1-infected individuals.

Authors:  I J Koralnik; J E Schmitz; M A Lifton; M A Forman; N L Letvin
Journal:  J Neurovirol       Date:  1999-08       Impact factor: 2.643

8.  Quantification of JC virus DNA in the cerebrospinal fluid of patients with human immunodeficiency virus-associated progressive multifocal leukoencephalopathy--a longitudinal study.

Authors:  C Eggers; H J Stellbrink; T Buhk; K Dörries
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

9.  Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals.

Authors:  K Dörries; E Vogel; S Günther; S Czub
Journal:  Virology       Date:  1994-01       Impact factor: 3.616

  9 in total
  14 in total

1.  JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis.

Authors:  Spyridon Chalkias; Xin Dang; Evelyn Bord; Marion C Stein; R Philip Kinkel; Jacob A Sloane; Maureen Donnelly; Carolina Ionete; Maria K Houtchens; Guy J Buckle; Stephanie Batson; Igor J Koralnik
Journal:  Ann Neurol       Date:  2014-06-10       Impact factor: 10.422

2.  Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab.

Authors:  Simone Giannecchini; Valeria Clausi; Alessandra Vultaggio; Lisa Macera; Fabrizio Maggi; Francesco Martelli; Alberta Azzi; Enrico Maggi; Andrea Matucci
Journal:  J Neurovirol       Date:  2012-01-27       Impact factor: 2.643

3.  Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.

Authors:  E Iacobaeus; C Ryschkewitsch; M Gravell; M Khademi; E Wallstrom; T Olsson; L Brundin; Eo Major
Journal:  Mult Scler       Date:  2008-09-19       Impact factor: 6.312

4.  Reply to letter to the editor: "JC viremia and multiple sclerosis" by Focosi et al.

Authors:  Serena Delbue; Franca Rosa Guerini; Roberta Mancuso; Domenico Caputo; Romina Mazziotti; Marina Saresella; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2008-01       Impact factor: 2.643

Review 5.  The role of polyomaviruses in human disease.

Authors:  Mengxi Jiang; Johanna R Abend; Silas F Johnson; Michael J Imperiale
Journal:  Virology       Date:  2008-11-07       Impact factor: 3.616

Review 6.  Update on PML: lessons from the HIV uninfected and new insights in pathogenesis and treatment.

Authors:  Elizabeth A Hartman; DeRen Huang
Journal:  Curr HIV/AIDS Rep       Date:  2008-08       Impact factor: 5.071

7.  Detection of the archetypal regulatory region of JC virus from the tonsil tissue of patients with tonsillitis and tonsilar hypertrophy.

Authors:  Atsushi Kato; Tadaichi Kitamura; Tomokazu Takasaka; Takashi Tominaga; Akira Ishikawa; Huai-Ying Zheng; Yoshiaki Yogo
Journal:  J Neurovirol       Date:  2004-08       Impact factor: 2.643

8.  Rearrangement patterns of JC virus noncoding control region from different biological samples.

Authors:  V Pietropaolo; M Videtta; D Fioriti; M Mischitelli; A Arancio; N Orsi; A M Degener
Journal:  J Neurovirol       Date:  2003-12       Impact factor: 2.643

Review 9.  JC virus: an oncogenic virus in animals and humans?

Authors:  Melissa S Maginnis; Walter J Atwood
Journal:  Semin Cancer Biol       Date:  2009-02-24       Impact factor: 15.707

10.  The RBP-Jκ binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation.

Authors:  Jie Lu; Subhash C Verma; Qiliang Cai; Abhik Saha; Richard Kuo Dzeng; Erle S Robertson
Journal:  PLoS Pathog       Date:  2012-01-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.